Department of Obstetrics and Gynaecology, Urogynaecology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Laboratory of Experimental Surgery and Surgical Research N S Christeas, University of Athens, Medical School, Athens, Greece.
Neurourol Urodyn. 2019 Feb;38(2):509-524. doi: 10.1002/nau.23871. Epub 2018 Nov 15.
The use of synthetic mesh in pelvic organ prolapse surgery is being closely scrutinized because of serious concerns regarding life-changing complications such as erosion, pain, infection, bleeding, dyspareunia, organ perforation, and urinary problems. Randomized trials and their syntheses in meta-analysis offer a unique opportunity to assess efficacy and safety. However, outcomes and outcome measures need to be consistently selected, collected, and reported across randomized trials to be effectively combined in systematic reviews.
We evaluated outcome and outcome measure reporting across randomized controlled trials on surgical interventions using synthetic mesh for pelvic organ prolapse.
Systematic review of randomized controlled trials using synthetic mesh for the treatment of pelvic organ prolapse. The selected studies were evaluated using Jadad and MOMENT criteria. Outcomes and outcome measures were systematically identified and categorized.
Seventy-one randomized trials were included. Twenty-four different types of mesh were identified. Included trials reported 110 different outcomes and 60 outcome measures. Erosion (40 trials, 78%), pain (29 trials, 56%), bleeding (31 trials, 61%), and dyspareunia (25 trials, 49%) were the most frequently reported outcomes. The longest follow up was 74 months.
Most randomized trials evaluating surgical interventions using synthetic mesh for pelvic organ prolapse failed to report on clinically important outcomes and to evaluate efficacy and safety over the medium- and long-term. Developing and implementing a minimum data set, known as a core outcome set, in future vaginal prolapse trials could help address these issues.
由于对严重并发症(如侵蚀、疼痛、感染、出血、性交困难、器官穿孔和尿失禁问题)改变生活的严重担忧,在盆腔器官脱垂手术中使用合成网片正受到密切审查。随机试验及其荟萃分析的综合提供了评估疗效和安全性的独特机会。然而,需要在跨随机试验中一致选择、收集和报告结果和结局测量,以便在系统评价中有效地进行组合。
我们评估了使用合成网片治疗盆腔器官脱垂的随机对照试验中的结局和结局测量报告。
对使用合成网片治疗盆腔器官脱垂的随机对照试验进行系统评价。使用 Jadad 和 MOMENT 标准评估所选研究。系统地确定和分类结局和结局测量。
纳入了 71 项随机试验。确定了 24 种不同类型的网片。纳入的试验报告了 110 种不同的结局和 60 种结局测量。侵蚀(40 项试验,78%)、疼痛(29 项试验,56%)、出血(31 项试验,61%)和性交困难(25 项试验,49%)是最常报告的结局。最长随访时间为 74 个月。
大多数评估使用合成网片治疗盆腔器官脱垂的手术干预的随机试验未能报告临床上重要的结局,也未能评估中至长期的疗效和安全性。在未来的阴道脱垂试验中开发和实施一个最小数据集,即核心结局集,可以帮助解决这些问题。